Filing status
- Accounts due
- 28 February 2026
- Last accounts
- 31 May 2024
- Conf. stmt due
- 1 May 2026
- Last conf. stmt
- 17 April 2025
Lunac Therapeutics Limited
- Incorporated
- 18 April 2018 (8 years)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Owned by
- Accounts type
- Small
- Region
- Greater London
- Address
- 29 Craven StreetLondonWC2N 5NT
Charges
- Total
- 1
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 0
Officers
Not loaded yet. See them on Companies House
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 20 September 2019
Owns 25–50% of shares
Holds 25–50% of voting rights
Private Fund Limited Partnership
Reg. no. Sl033678
Former controllers (1)
6 May 2020
Ceased Caribou Property Ltd — Owns 25–50% of shares
Group structure 26 shown
Ownership group derived from the Companies House PSC register
BBB Investment Holdings Limited Owns 75–100% of shares
BBB Investment Services Limited Owns 75–100% of shares
BBB Mandates Limited Owns 75–100% of shares
BGP General Partner I LLP Holds 75–100% of voting rights
British Business Access Lending Limited Owns 75–100% of shares
British Business Investments Ltd Owns 75–100% of shares
Federated Hermes Private Equity Innovation II LP Part right to 25–50% of surplus assets
Hermes Gpe Environmental Innovation Fund LP Part right to 25–50% of surplus assets
Hermes Gpe Innovation Fund LP Part right to 25–50% of surplus assets
UK FTF L.P. Holds 25–50% of voting rights
British Patient Capital Limited Owns 75–100% of shares
Epidarex Capital IV, LP Part right to 25–50% of surplus assets
Nations and Regions Investments Limited Owns 75–100% of shares
British Business Finance Ltd Owns 75–100% of shares
British Business Aspire Holdco Ltd Owns 75–100% of shares
Capital for Enterprise Fund L.P. Holds 50–75% of voting rights
Epidarex Capital Iii UK, LP Part right to 25–50% of surplus assets
Epidarex Exeed Limited Owns 75–100% of shares
Lario Therapeutics Limited Owns 50–75% of shares
Lunac Therapeutics Limited This company In liquidationOwns 25–50% of shares
Macomics Ltd Owns 25–50% of shares
Rinn Therapeutics Limited Owns 75–100% of shares
Passion Capital GC (FP) LLP Right to 50–75% of surplus assets
Pentech Fund Iii Limited Partnership Part right to 25–50% of surplus assets
The Start-Up Loans Company Right to appoint and remove directors
Financials
Balance sheet as at 31 May 2024 · small accounts
- Net Assets
- (£3,928,384)
- Cash
- £774,992
- Employees
- 1
- Debt Ratio
- 566%
- Current Ratio
- 12.5x
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | |
|---|---|---|
| Fixed Assets | £0 | £617 |
| Current Assets | £843,803 | £1,196,999 |
| Debtors | £68,811 | £741,830 |
| Cash | £774,992 | £455,169 |
| Creditors (< 1 year) | £67,643 | £4,808,178 |
| Creditors (> 1 year) | £4,704,544 | £0 |
| Net Current Assets | £776,160 | (£3,611,179) |
| Net Assets | (£3,928,384) | (£3,610,562) |
| Shareholder Funds | (£3,928,384) | (£3,610,562) |
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
Sandwich
Melbourn
London
Edinburgh
West Mains Road
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →